The American Academy of Otolaryngic Allergy (AAOA) represents over 2,700 Board-certified otolaryngologists and health care providers. Otolaryngology, frequently referred to as Ear, Nose, and Throat (ENT), uniquely combines medical and surgical expertise to care for patients with a variety of conditions affecting the ears, nose, and throat, as well as commonly related conditions. AAOA members devote part of their practice to the diagnosis and treatment of allergic disease. The AAOA actively supports its membership through education, research, and advocacy in the care of allergic patients.
"Advance the comprehensive management of allergy and inflammatory disease in Otolaryngology-Head and Neck Surgery through training, education, and advocacy."
As part of our on-going member support, we are introducing a new website feature to help with common practice management challenges. We welcome your input with questions or challenges you would like to address. Read More
AMA Advocacy Update The House of Representatives voted 339-85 on March 6 to pass the…
The Centers for Medicare & Medicaid Services recently sent a memo to Medicare Advantage (MA)…
Please take the time to complete the Physician Practice Information Survey! If you or your…
12/01/24: Research Grant Cycle
Learn more
04/01/25: Fellow Exam Application Deadline
Learn more
06/01/25: Research Grant Cycle
Learn more
08/08/25: Scientific Abstract Submission Deadline
Learn more
Thanks to your feedback, we have reimagined our Advanced Course in Allergy & Immunology to give you educational programming that encompasses your full scope of practice. Join us for the new Explorers Course 2025: Surgical & Medical Management of Airway Disease in Otolaryngology. Learn More
We are pleased to invite you to participate in the 2025 AAOA Annual Meeting Call for Proposals. Do you have burning content ideas to be presented at the Annual Meeting? The AAOA is seeking proposals to incorporate in the educational sessions for the 2025 Annual Meeting. Learn More
For information about Resident membership, opportunities, DosedDaily, research grants, and other resources. Learn More
IFAR Impact Factor: 2.454
IFAR Featured Content: COVID-19 - Free Access
Endonasal instrumentation and aerosolization risk in the era of COVID‐19: simulation, literature review, and proposed mitigation strategies . Read More
2024 AAOA Annual Meeting - Hybrid
November 8-10, 2024
Four Seasons Hotel Las Vegas
Learn More and Register
Explorers Course 2025:
Surgical & Medical Management of Airway Disease in Otolaryngology — Hybrid
90-days Access Feb 27 – May 27, 2025
March 27-29, 2025 - Live
The Hythe, Vail, CO
Learn More and Register
2025 AAOA Basic Course in Allergy & Immunology - Hybrid
90-days Access June 10 – Sep 15, 2025
July 10-12, 2025 - Live
The Chateaux Deer Valley, Park City, UT
Book Your Room
USP 797 Online Module
Learn More and Register
AAOA Educational Stacks
Available Now!
November 9 - Billy Joel & Sting at Allegiant Stadium One of the highest-grossing touring…
I am writing this with The Beatles, “Here Comes the Sun,” streaming in the background…
Are you missing rare eosinophilic disease diagnoses? Join an expert multidisciplinary panel for a podcast…
The American Academy of Otolaryngic Allergy (AAOA) Practice Resource Tool Kit is intended as a guide to help AAOA members integrate allergy into their otolaryngology practice and to continually improve on this integration as new information, regulations, and resources become available.
AAOA has launched a Partner Resource Center to bring you partner resources that can assist your practice and patient care.
3 key compliance criteria The new USP General Chapter <797> Sterile Compounding went into effect November 1 2023. Now is a great time to review your in-office procedures to assure compliance. Below is the list of 3 key compliance criteria all compounding personnel…
Cost: $125 for AAOA members and $300 for non-members* in addition to AAOA Advanced Course registration When: Prior the beginning of the Advanced Course from 10 AM until 12 PM on December 12, 2019. This paid workshop includes: A two-hours session on…
The United States Pharmacopeia announced that, due to appeals underway, the previously announced implementation date of December 1, 2019 for Chapter 797 on Pharmaceutical Compounding of Sterile Preparations is officially postponed. Read more here. We do not know at this…
Final Standards for Allergen Extract Compounding under USP Chapter 797 The long-awaited new USP Chapter 797 standards on sterile compounding were released June 1 and take effect Dec. 1. Read the final approved USP letter here. Have questions? Attend the AAOA…
Specialty Impact The conversion factor for 2019 will be $36.0391 and remains essentially flat. The changes in the rule are budget-neutral in the aggregate which explains why the impact for all physicians is shown as zero. The final rule shows changes…
I want to urge you to consider membership in the AMA because your membership in AMA gives us a voice. The American Medical Association is one organization that the AAOA works through to advocate for issues related to the AAOA. …
Revisions to USP Chapter 797 Open for Comment Since the United States Pharmacopeia (USP) released a proposed update to Chapter 797 in 2015, AAOA has been working with other concerned organizations including the American Academy of Allergy, Asthma & Immunology,…
On November 1, the Centers for Medicare and Medicaid Services released the final Physician Fee Schedule (PFS) detailing policies related to Medicare physician payment and the Quality Payment Program (QPP). A brief summary of key provisions for AAOA members follows:…
The Food and Drug Administration (FDA) states, in a revised draft guidance released this week, that it does not intend to enforce the “insanitary conditions” provision of the Food, Drug and Cosmetic Act against physicians that compound or mix in their…
The Advocacy Council of the American College of Allergy, Asthma and Immunology (ACAAI) together with its sponsoring organization, the ACAAI, the American Academy of Allergy, Asthma and Immunology (AAAAI), and the American Academy of Otolaryngic Allergy (AAOA) submitted comments on the proposed changes…
